Author:
Qu Peng-Fei,Xu Chi,Fu Jun,Li Rui,Chai Wei,Chen Ji-Ying
Abstract
Abstract
Purpose
The diagnosis of persistent infection at reimplantation of two-stage revision arthroplasty for periprosthetic joint infection (PJI) remains challenging. Several studies have shown the benefit of serum interleukin-6 (IL-6) in diagnosing periprosthetic joint infection (PJI). Recent data indicated serum IL-6 could be promising in differentiating persistent infection. The purpose of this study was to validate the efficacy of serum IL-6 in diagnosing persistent infection at reimplantation.
Methods
A retrospective review of 86 PJI patients with a two-stage exchanged hip arthroplasty from 2013 to 2017 was conducted. Persistent infection was defined using the modified Musculoskeletal Infection Society (MSIS) criteria combined with follow-up results. Serum IL-6 at reimplantation were collected and compared among patients with or without persistent infection. Receiver operating characteristic (ROC) curves were generated to evaluate the diagnostic performance and optimal cut-off value of serum IL-6 at reimplantation.
Results
Sixteen cases were diagnosed as persistent infection at reimplantation. There was no significant difference in serum IL-6 levels between cases with persistent infection and controls (7.89 pg/ml vs. 5.56 pg/ml; P = 0.179). The area under the ROC curve (AUC) for serum IL-6 in diagnosing persistent infection at reimplantation was 0.59 (95% confidential interval [CI] 0.40–0.77). With the calculated threshold set at 8.12 pg/ml, the corresponding sensitivity, specificity, positive predictive value, and negative predictive values were 38%, 88%, 38%, and 87%, respectively.
Conclusion
Serum IL-6 is inadequate in diagnosing persistent infection at reimplantation for two-stage revision arthroplasty. With the serum IL-6 threshold set at 8.12 pg/ml, the specificity to rule out persistent infection is high, but the sensitivity to predict persistent infection is not satisfactory.
Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine,Surgery
Reference22 articles.
1. Alp E, Cevahir F, Ersoy S, et al. Incidence and economic burden of prosthetic joint infections in a university hospital: a report from a middle-income country. J Infect Public Health. 2016;9(4):494–8.
2. Gundtoft PH. Prosthetic joint infection following total hip arthroplasty—incidence, mortality and validation of the diagnosis in the Danish Hip Arthroplasty Register. Dan Med J. 2017;64(9):B5397.
3. Wang Q, Goswami K, Kuo FC, et al. Two-stage exchange arthroplasty for periprosthetic joint infection: the rate and reason for the attrition after the first stage. J Arthroplast. 2019.
4. Dwyer MK, Damsgaard C, Wadibia J, et al. Laboratory tests for diagnosis of chronic periprosthetic joint infection can help predict outcomes of two-stage exchange. J Bone Joint Surg Am. 2018;100(12):1009–15.
5. Khan N, Parmar D, Ibrahim MS, et al. Outcomes of repeat two-stage exchange hip arthroplasty for prosthetic joint infection. Bone Joint J. 2019;101-b(6_Supple_B):110–5.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献